Julia Lainster

A landmark multinational study has successfully validated a blood test for diagnosing Alzheimer’s disease and frontotemporal lobar degeneration within diverse Latin American populations, addressing a critical disparity in dementia diagnostics. Historically, the science behind these promising blood

We are joined today by Ivan Kairatov, a biopharma expert at the forefront of medical technology and innovation. We will be exploring a groundbreaking AI-powered tool that promises to transform the early detection of heart valve disease, a condition often called a "silent epidemic." Our conversation

The landscape of hematology is undergoing a significant transformation, driven by a new consensus that seeks to correct decades of suboptimal outcomes for a frequently overlooked demographic caught between two distinct worlds of medical care. For years, adolescents and young adults (AYAs) diagnosed

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

The quiet aftermath of a traumatic event often conjures images of panicked awakenings and a constant state of high alert, yet for the vast majority of survivors, the most debilitating struggle is a silent, internal battle waged not against terror but against a crushing weight of sorrow and

The emergence of cell-cultured protein has sparked intense debate at the intersection of agricultural tradition and technological innovation, nowhere more so than in states with deep roots in the livestock industry. In South Dakota, a legislative effort to completely prohibit the sale of lab-grown

The ever-increasing complexity and volume of medical imaging have pushed modern radiology to a critical juncture, where the demand for expert interpretation often outstrips the available clinical capacity. The rise of artificial intelligence represents a significant advancement in the medical

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

Today, we sit down with Ivan Kairatov, a biopharma expert whose career has been dedicated to the intersection of technology, research, and development. As artificial intelligence begins to unlock the very code of life, it presents a dual-use dilemma of unprecedented scale—promising revolutionary

A promise of universal health care, once the gleaming centerpiece of Governor Gavin Newsom's progressive agenda for California, now appears tarnished by the harsh glare of fiscal austerity and national political ambition. The governor's controversial proposal to withhold state funding for health